Pages that link to "Q36325476"
Jump to navigation
Jump to search
The following pages link to Hormone replacement therapy is associated with decreased survival in women with lung cancer. (Q36325476):
Displaying 50 items.
- Lung cancer chemoprevention: current status and future prospects (Q26995495) (← links)
- Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers Study (Q28391500) (← links)
- Estrogen receptor signaling in lung cancer (Q28393484) (← links)
- Population-based trends in lung cancer incidence in women (Q28394485) (← links)
- Early changes in pulmonary gene expression following tobacco exposure shed light on the role of estrogen metabolism in lung carcinogenesis (Q28396012) (← links)
- Targeting the estrogen pathway for the treatment and prevention of lung cancer (Q28397456) (← links)
- The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer (Q28397662) (← links)
- Lung cancer in women (Q29248783) (← links)
- Exploring estrogenic activity in lung cancer (Q29248785) (← links)
- Lung cancer in never smokers--a different disease (Q29615414) (← links)
- DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type (Q30494942) (← links)
- Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study (Q33770389) (← links)
- Early changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue (Q33958919) (← links)
- Identification of collaboration patterns of dysfunctional pathways in breast cancer (Q34028990) (← links)
- Lung cancer screening: a review of available data and current guidelines (Q34067949) (← links)
- Lung cancer in women: role of estrogens (Q34083747) (← links)
- Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial (Q34145853) (← links)
- Survival in women with NSCLC: the role of reproductive history and hormone use. (Q34235471) (← links)
- Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women (Q34310409) (← links)
- Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial (Q34370566) (← links)
- Significance of the progesterone receptor and epidermal growth factor receptor, but not the estrogen receptor, in chemically induced lung carcinogenesis in female A/J mice (Q34427354) (← links)
- Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis (Q34963585) (← links)
- Estrogen adversely affects the prognosis of patients with lung adenocarcinoma. (Q35051314) (← links)
- Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer (Q35085764) (← links)
- Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer (Q35187806) (← links)
- Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy (Q35250302) (← links)
- 30th german cancer congress, 22nd-25th february 2012, berlin (Q35883058) (← links)
- Sex differences and sex steroids in lung health and disease (Q36003356) (← links)
- Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab (Q36286698) (← links)
- Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration (Q36413817) (← links)
- Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens. (Q36646986) (← links)
- Prediagnosis soy food consumption and lung cancer survival in women (Q36763839) (← links)
- Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma (Q36775374) (← links)
- The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism (Q36782636) (← links)
- Paclitaxel poliglumex (PPX, CT-2103): macromolecular medicine for advanced non-small-cell lung cancer (Q36788450) (← links)
- Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: can an association be confirmed? (Q37225785) (← links)
- ErbBs in lung cancer (Q37249978) (← links)
- Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development (Q37354444) (← links)
- Targeting aromatase and estrogen signaling in human non-small cell lung cancer (Q37435616) (← links)
- Antiproliferative effect of exemestane in lung cancer cells (Q37460552) (← links)
- Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population (Q37519509) (← links)
- Smoking out reproductive hormone actions in lung cancer (Q37679479) (← links)
- Estrongenic steroid hormones in lung cancer (Q37726987) (← links)
- Postmenopausal hormone therapy and lung cancer (Q37800495) (← links)
- Estrogen receptors, antiestrogens, and non-small cell lung cancer (Q37840205) (← links)
- Suppression of estrogen actions in human lung cancer (Q37847499) (← links)
- Lung cancer in never smokers. (Q37944937) (← links)
- Antiestrogen use and survival of women with non-small cell lung cancer in Manitoba, Canada (Q38110168) (← links)
- Estrogen receptor signaling pathways in human non-small cell lung cancer (Q38434138) (← links)
- Estrogen and cancers of the colorectum, breast, and lung in postmenopausal women (Q38540913) (← links)